Rhythm Pharmaceuticals, Inc. (RYTM)
92.83
-0.58
(-0.62%)
USD |
NASDAQ |
Oct 02, 16:00
92.86
+0.02
(+0.03%)
After-Hours: 20:00
Rhythm Pharmaceuticals Market Cap : 6.388B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 6.388B |
| October 01, 2026 | 6.428B |
| September 30, 2026 | 6.552B |
| September 29, 2026 | 6.586B |
| September 28, 2026 | 6.783B |
| September 25, 2026 | 6.789B |
| September 24, 2026 | 6.765B |
| September 23, 2026 | 6.761B |
| September 22, 2026 | 6.831B |
| September 21, 2026 | 6.801B |
| September 18, 2026 | 6.724B |
| September 17, 2026 | 6.814B |
| September 16, 2026 | 6.745B |
| September 15, 2026 | 6.659B |
| September 14, 2026 | 7.050B |
| September 11, 2026 | 7.206B |
| September 10, 2026 | 7.033B |
| September 09, 2026 | 6.955B |
| September 08, 2026 | 7.006B |
| September 04, 2026 | 7.070B |
| September 03, 2026 | 7.218B |
| September 02, 2026 | 7.255B |
| September 01, 2026 | 7.208B |
| August 31, 2026 | 7.304B |
| August 28, 2026 | 7.375B |
| Date | Value |
|---|---|
| August 27, 2026 | 7.744B |
| August 26, 2026 | 7.699B |
| August 25, 2026 | 7.800B |
| August 24, 2026 | 7.669B |
| August 21, 2026 | 7.570B |
| August 20, 2026 | 7.496B |
| August 19, 2026 | 7.964B |
| August 18, 2026 | 7.931B |
| August 17, 2026 | 7.944B |
| August 14, 2026 | 7.947B |
| August 13, 2026 | 7.984B |
| August 12, 2026 | 8.093B |
| August 11, 2026 | 7.766B |
| August 10, 2026 | 7.947B |
| August 07, 2026 | 7.957B |
| August 06, 2026 | 7.714B |
| August 05, 2026 | 7.578B |
| August 04, 2026 | 7.240B |
| August 03, 2026 | 7.035B |
| July 31, 2026 | 6.793B |
| July 30, 2026 | 7.237B |
| July 29, 2026 | 7.291B |
| July 28, 2026 | 7.395B |
| July 27, 2026 | 7.264B |
| July 24, 2026 | 6.988B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 29.38B |
| BioMarin Pharmaceutical, Inc. | 11.07B |
| Cytokinetics, Inc. | 9.103B |
| Exelixis, Inc. | 14.53B |
| Ionis Pharmaceuticals, Inc. | 7.212B |
Market Cap Related Metrics
| PS Ratio | 26.09 |
| PEG Ratio | -8.995 |
| Price to Book Value | 62.03 |
| Price | 92.83 |
| Earnings Yield | -3.36% |
| PEGY Ratio | -8.995 |